CTMCF yields 1597.44% · PFE yields 6.13%● Live data
📍 CTMCF pulled ahead of the other in Year 1
Combined, CTMCF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTMCF + PFE for your $10,000?
Canterra Minerals Corporation, a resource company, engages in the acquisition, exploration, and evaluation of mineral properties in the Northwest Territories and Alberta. It holds diamond properties in the Northwest Territories and Alberta, as well as focuses on gold exploration in Newfoundland. The company holds interest in the Wilding gold project covering an area of 23,600 hectares located in central Newfoundland; Buffalo Hills property that comprises 21 mineral leases covering an area of 4,848 hectares located in Alberta, Canada; and the Clipper Brook property that comprises of 5 mineral licenses totaling 122.5 square kilometers located to the northeast strike extent of the Rogerson Lake Structural Corridor. It also holds an option agreement to acquire a 100% interest in the East Alder gold project located in central Newfoundland. The company was formerly known as Diamondex Resources Ltd. and changed its name to Canterra Minerals Corporation in December 2009. Canterra Minerals Corporation was incorporated in 1999 and is headquartered in Vancouver, Canada.
Full CTMCF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.